Philip Knuckles
Principal Scientist Genetics and Genomics at Roche | Basel, Basel, Switzerland
Philip Knuckles’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Principal Scientist Genetics and Genomics at Roche in October 2025 - Present
Senior Scientist Genetics & Genomics at Roche in June 2021 - October 2025
Director Biomarker Discovery at Scailyte AG in January 2021 - June 2021
Senior Scientist in Biomarker Discovery at Scailyte AG in February 2019 - December 2020
Scientific Consultant at SunRegen Healthcare AG in July 2018 - December 2020
Postdoctoral Fellow at Friedrich Miescher Institute for Biomedical Research in February 2011 - January 2019
PhD focus on Developmental Neurobiology at Max-Planck Institute of Immunobiology and Epigenetics in March 2007 - May 2011
Clinical Research Associate at Eli Lilly and Company in January 2006 - December 2007
The University of Freiburg, Doctor of Philosophy (Ph.D.), October 2026
Universidad Nacional Autónoma de México, Master of Science (M.S.), October 2026
Austin College, Bachelor of Arts (B.A.), October 1998 to October 2026
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Discover more about Roche
Head of Middle East Clinical Operations Hub at Roche
Head of Middle East Clinical Operations Hub at Roche
(December 2017 – Present)
Affiliate Quality Manager & SHE Officer at Roche
Affiliate Quality Manager & SHE Officer at Roche
(September 2024 – Present)
Hematology & Immunology partner
Immuonolgy & Hematology Partner at Roche
(June 2023 – Present)
Patient Journey Partner en Roche
PATIENT JOURNEY PARTNER - ONCOLOGY at Roche
(August 2023 – Present)
Breaking Down Barriers: Expanding Access to Quality Healthcare
Patient Journey Partner at Roche
(December 2024 – Present)
Neurorradiologo
Médico Radiologo at Sabbag Radiologos
(February 2019 – Present)
What is Philip Knuckles email address?
Email Philip Knuckles at [email protected]. This email is the most updated Philip Knuckles's email found in 2026.
How to contact Philip Knuckles?
To contact Philip Knuckles send an email to [email protected]. (updated on November 17, 2025)
What company does Philip Knuckles work for?
Philip Knuckles works for Roche.
What is Philip Knuckles's role at Roche?
Philip Knuckles is Principal Scientist Genetics and Genomics
What industry does Philip Knuckles work in?
Philip Knuckles works in the Biotechnology industry.
